Both in Lab Analytical Instruments
Quanterix vs Harvard Bioscience
Over the past year QTRX returned −45.6% and HBIO returned +72.3%; their daily moves had a correlation of 0.02.
QTRX −45.6% HBIO +72.3%Growth of $1, one year, split-adjusted
| Metric | QTRX | HBIO |
|---|---|---|
| Price | $2.91 | $8.90 |
| Market cap | $137.4M | $40.5M |
| Today | −7.63% | +1.14% |
| 1 month | −14.8% | +9.5% |
| 6 months | −14.6% | +39.9% |
| Year to date | −54.3% | +33.1% |
| 1 year | −43.8% | +99.3% |
| Revenue growth (YoY) | +34.4% | +11.1% |
| Gross margin | 38.5% | 55.6% |
| Net margin | −148.7% | −12.8% |
| P/E (TTM) | — | — |
| Price / sales | 0.9× | 0.5× |
| Net cash | $93.5M | -$30.2M |
| Dividend yield | — | — |
| Volatility (60d) | 133.2% | 36.4% |
| Short % of float | 10.8% | 1.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).